Conferences and Meetings

CSANZ Annual Scientific Meeting, Perth, Western Australia

(11^th -14^th August 2011)

Anticoagulation in Atrial Fibrillation – From Evolution to Revolution

Thursday 11^th August 2011

River View Room 5, Level 2, Perth Convention Centre at 7.00pm

Anticoagulation in Atrial Fibrillation is a dinner symposium presented by CCRE Therapeutics at the 2011 Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, sponsored by an unencumbered educational grant from Boehringer Ingelheim.  Local and international speakers will provide insight into new approaches for stroke prevention in atrial fibrillation.

Guest Speakers:
A/Prof John Eikelboom, McMaster University, Ontario, Canada
Prof John Amerena, Geelong Hospital, Victoria, Australia
Prof Graeme Hankey, Royal Perth Hospital, WA

To register your attendance for this symposium please click here. 

CSANZ Annual Meeting (5th - 8th August, 2010)

CSL Heart Failure Symposium 

Thursday 5th August 2010 - 7pm

CCRE Therapeutics ran a satellite dinner symposium "Heart Failure and Co-Morbidities in the Elderly: Impact of Beta-Blockers" at the 2010 Annual Meeting of the Cardiac Society of Australia and New Zealand sponsored by an unencumbered educational grant from CSL Biotherapies. 

Guest speakers:

• Dr Marcus Flather, Imperial College, London
• Prof Andrew Coats, University of Sydney
• Prof Dirk van Veldhuisen, University Medical Centre Groningen, Netherlands

Abbott Omega-3 Symposium 

Friday 6th August 2010 - 6.30pm

CCRE Therapeutics organised a satellite  symposium "Omega-3 Fatty Acids and Cardiovascular Disease: The Evidence Span from Bench to Bedside" at the 2010 Annual Meeting of the Cardiac Society of Australia and New Zealand sponsored by an unencumbered educational grant from Abbott. 

Guest speakers:

• Prof Peter McLennan, University of Wollongong
• Dr Maria Grazia Fanzosi, Mario Negri Institute Milan, Italy
• Prof David Colquhoun, University of Queensland

CSANZ Annual Meeting (13th Aug-16th Aug 2009)

"The Role of Biomarkers in CVD Risk Assessment" 

Friday 14th August, 5.30pm-7.00pm

This symposium was sponsored by an unrestricted educational grant from AstraZeneca.

Guest Speakers:

• Prof Andrew Tonkin, Monash University, Melbourne
• Dr Paul Ridker, Brigham and Women's Hospital, Boston, USA
• Prof Stefan Blankenberg, Johannes Gutenberg-University, Germany

"Modern Management of Heart Failure" 

Friday 14th August, 5.30pm-7.00pm

This symposium was sponsored by an unrestricted educational grant from CSL Biotherapies.

Guest Speakers:

• Prof Andrew Coats, University of Sydney
• Dr Marcus Flather, Royal Brompton Hospital, London, UK
• Prof Henry Krum, Monash University, Melbourne

4th Asian Pacific Congress of Heart Failure (31st Jan-3 Feb 2008)

The Asia Pacific Society of Cardiology held its 4th Asian Pacific Congress of Heart Failure in Melbourne attended by 800 delegates.  

CCRE Therapeutics ran a highly successful satellite symposium entitled "Novel Therapeutic Approaches to the Management of Chronic Heart Failure: Role of Third Generation Beta-blockers".  This symposium was sponsored by an unrestricted educational grant from CSL Biotherapies.

For further information download the symposium program (316kb).

CSANZ Annual Meeting (7th-10th Aug 2008)

CCRE Therapeutics organised a satellite symposium entitled "Anti-Platelet Therapy" at the Annual Meeting of the Cardiac Society of Australia and New Zealand sponsored by an unrestricted educational grant from Bristol-Myers Squibb. 

Guest speakers included the internationally renowned  Prof Barry Massie from the University of California.

Download the symposium program (pdf 228kb) for more information.